Clinically significant azole cross‐resistance in Candida isolates from HIV‐positive patients with oral candidosis

@article{Cartledge1997ClinicallySA,
  title={Clinically significant azole cross‐resistance in Candida isolates from HIV‐positive patients with oral candidosis},
  author={J. Cartledge and J. Midgley and B. Gazzard},
  journal={AIDS},
  year={1997},
  volume={11},
  pages={1839–1844}
}
  • J. Cartledge, J. Midgley, B. Gazzard
  • Published 1997
  • Medicine
  • AIDS
  • Objectives:To determine the proportion of fluconazole-resistant Candida albicans isolates that have clinically significant cross-resistance to itraconazole or ketoconazole, that is sufficient to result in failure of these agents at their standard doses (200 and 400 mg daily for 7 days, respectively). Methods:Seven hundred C. albicans isolates from HIV-positive patients with oral candidosis underwent susceptibility testing using a relative growth method, for which cut-off values corresponding to… CONTINUE READING

    Topics from this paper.

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 23 REFERENCES
    Characterization of an azole-resistant Candida glabrata isolate.
    • 199
    • PDF
    Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents.
    • 58
    • Highly Influential
    • PDF
    Azole drug resistance in Candida species.
    • 40
    • PDF
    Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS).
    • 183
    • Highly Influential